Arkolith/Insider Trading/RAPH/Form 4

Eliya Yehuda

DirectorRaphael Pharmaceutical Inc. (RAPH) · full profile →Form 4 · filed Mar 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Grant(A)200K—$0200K
May 12, 2022Expiration(E)202K—$00

Transaction Codes

A
Grant / award
E
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-023367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML